The global bioinformatics market is anticipated to grow at a CAGR of 12.3% during the forecast period (2023-2030). The rising prevalence of chronic diseases like cancer and genetic disorders increases demand for advanced bioinformatics tools and solutions. Bioinformatics plays a crucial role in analyzing vast amounts of genomic data to identify genetic variations associated with diseases and develop targeted therapies. The growing adoption of next-generation sequencing (NGS) technologies has generated vast amounts of genomic data, necessitating advanced bioinformatics solutions for data analysis and interpretation that drive market growth.
Browse the full report description of “Bioinformatics Market Size, Share & Trends Analysis Report by Product & Services (Knowledge Management Tools, Bioinformatics Platforms and Bioinformatics Services), by Application (Metabolomics, Transcriptomics, Proteomics, Genomics and Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/bioinformatics-market
To improve the quality of the NGS pipeline by scaling testing analytics while processing large sample volumes and supporting rapid turnaround times. The latest version of bioinformatics processes samples about two times as fast as traditional use, enabling shorter test turnaround times and lower processing costs. For instance, in March 2022, ARUP launched a new bioinformatics platform for better, faster next-generation sequencing test results. Rio amplifies ARUP’s existing cloud computing capabilities to move data more efficiently and with greater accuracy to speed targeted test results to clinicians for analysis and improved medical decision-making for patients.
From promising drug development, diagnosis of genetic disease, and the realization of personalized medicine, the bioinformatics platform helps speed discovery in genomic research. For instance, in October 2022, Almaden Genomics launched g.nome™, a cloud-native platform designed to streamline genomic workflows and accelerate genomic discovery. An advanced visual drag-and-drop workflow builder and curated library of toolkits, g.nome enables users to have confidence in their results, get to market faster and scale their business profitably.
Bioinformatics Services offers a comprehensive platform of advanced data solutions tailored to meet the specific needs of clients in academia, healthcare, and pharmaceutical research. For instance, in July 2023, FOXO Technologies Inc., in the field of commercializing epigenetic biomarker technology, launched of its innovative bioinformatics services to accelerate breakthroughs in biology, biotechnology, and healthcare, and redefine the growing field of epigenetic research.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product & Services
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Illumina Inc., Qiagen N.V., Thermo Fisher Scientific Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Bioinformatics Market Report Segment
By Product & Services
By Application
Global Bioinformatics Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bioinformatics-market